Results 111 to 120 of about 38,609 (257)

Sex Differences in Medication Discontinuation in Axial Spondyloarthritis

open access: yesArthritis Care &Research, EarlyView.
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or JAK inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we assessed ...
Rachael Stovall   +9 more
wiley   +1 more source

Safety and efficacy of extended versus standard interval dosing of anti-CD20 therapy in multiple sclerosis – A meta-analysis

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical
Background Anti-CD20 therapy is a highly effective multiple sclerosis (MS) disease-modifying therapy, but may be complicated by infections, which has led to the utilization of different extended interval dosing (EID) regimens.
Mahmoud Elkhooly   +2 more
doaj   +1 more source

Temporal Trends and Short‐ and Long‐Term Mortality of People With Acute Myocardial Infarction and Rheumatoid Arthritis: A Nationwide Cohort Study

open access: yesArthritis Care &Research, EarlyView.
Objective We investigated whether a diagnosis of rheumatoid arthritis (RA) affects the quality of inpatient acute myocardial infarction (AMI) care and long‐term mortality post‐AMI. Methods We analyzed data from 784,091 adults, 6,047 with a diagnosis of RA, from England and Wales hospitalized with AMI between 2005 and 2019 from the Myocardial Ischaemia ...
Megan Butler   +8 more
wiley   +1 more source

Six‐Month Benralizumab Maintenance for Relapsing Chronic Eosinophilic Pneumonia Guided by Eosinophil Kinetics

open access: yesRespirology Case Reports
Idiopathic chronic eosinophilic pneumonia (ICEP) often relapses upon corticosteroid tapering. Biologics targeting interleukin‐5 (IL‐5) are effective, but optimal dosing intervals remain unclear. We report a case of relapsing ICEP in a patient in her 50s.
Toshiyuki Sumi   +6 more
doaj   +1 more source

Evaluation of Large Dose, Extended Interval Aminoglycoside Dosing Protocols Using Pharmacokinetic Data from 515 Patients

open access: yes, 2011
Class of 2011 AbstractOBJECTIVES: The purpose of this study is to assess three published aminoglycoside dosing protocols (large-dose extended interval), to predict peak and trough concentrations of these protocols and to determine the percentage of ...
Vu, Peter
core  

Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry

open access: yesArthritis Care &Research, EarlyView.
Objective Mycophenolate mofetil (MMF) use in limited cutaneous systemic sclerosis (lcSSc) is relatively uncommon because of the lower fibrotic burden and the predominance of vascular complications. In vitro observations and clinical data from transplanted patients suggest a protective effect of MMF on endothelial function.
Enrico De Lorenzis   +77 more
wiley   +1 more source

Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis

open access: yesFrontiers in Immunology
Natalizumab, a monoclonal antibody used to treat multiple sclerosis, can undergo Fab-arm exchange (FAE) with endogenous IgG4, resulting in a monovalent form with reduced avidity and presumed lower potency than the parental bivalent form.
Liza M.Y. Gelissen   +13 more
doaj   +1 more source

Extended-Interval Aminoglycoside (EIA) Regimen – Focus on Gentamicin and Amikacin

open access: yes, 2007
在胺基配醣體類抗生素 (aminoglycoside antibiotics) 的使用上,延長給藥間隔能夠提高治療效果同時降低毒性發生率﹔其設計基礎是建立於胺基配醣體類抗生素的三種特性﹕殺菌效果的濃度依賴性 (concentration-dependent bactericidal activity)、抗生素後效應 (post-antibiotic effect)、以及適應性抗藥性 (adaptive resistance)。 本研究採用回朔性方法 ...
賴俐君, Lai, Lily Li-Chun
core  

Marked Long‐Term Improvement in Lung Function in Melanoma Differentiation–Associated Protein 5 Antibody–Positive Dermatomyositis Patients: Experience of a Single‐Center Longitudinal Cohort in North America

open access: yesArthritis Care &Research, EarlyView.
Objective The objective of this study was to describe the longitudinal disease course and pulmonary outcomes of North American patients with melanoma differentiation–associated protein 5 (MDA5) antibody–associated dermatomyositis (DM). Methods Thirty patients with MDA5 antibody–associated DM were identified in a single‐center longitudinal cohort of 352
Jenice X. Cheah   +8 more
wiley   +1 more source

SARS-CoV-2 vaccination strategies: Should the extended dosing interval strategy be implemented in future pandemics?

open access: yesTravel Medicine and Infectious Disease, 2023
Sandra Valderrama-Beltrán   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy